![](/img/cover-not-exists.png)
Letter to the editor concerning first-line therapy with afatinib – an irreversible EGFR TKI and overall survival of NSCLC patients with EGFR gene mutations
Krawczyk, Paweł, Powrózek, Tomasz, Nicoś, Marcin, Milanowski, JanuszVolume:
3
Year:
2015
Language:
english
Journal:
Współczesna Onkologia
DOI:
10.5114/wo.2015.52660
File:
PDF, 39 KB
english, 2015